FdaApplication
NDA 020347
Identifiers
- fda_app_no: NDA020347
Properties
| Property | Value |
|---|---|
| applicant_name | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
| application_type | NDA |
| approval_date | 1994-12-14 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYTRIN | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| HYTRIN | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| HYTRIN | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| HYTRIN | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
4 products